Does plasma phoenixin level associate with cognition? Comparison between subjective memory complaint, mild cognitive impairment, and mild Alzheimer's disease
Tarih
2017Yazar
Emul, Murat
Yavuzer, Hakan
Batun, Gizem Cetiner
Gultekin, Gozde
Doventas, Alper
Akcan, Fundan Engin
Yuruyen, Mehmet
Üst veri
Tüm öğe kaydını gösterÖzet
Background: Alteration in energy expenditure or metabolism is the most accused risk issue for the onset and for the course of neurodegenerative cognitive disorders. Neuropeptides are suggested to be related with learning and memory. Phoenixin (PNX) is the most recently reported neuropeptide and we aimed to compare the plasma level in people with subjective memory complaints, patients with mild cognitive impairment, and mild Alzheimer's disease (AD).
Koleksiyonlar
- Makale [92796]